Li Xiao
- Topics
- Ovarian cancer diagnosis and treatment (3 papers)Hepatitis B Virus Studies (3 papers)Hepatitis C virus research (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Li Xiao
18 papers receiving 346 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 108
- Reproductive Medicine 77
- Immunology 67
- Hepatology 62
- Cancer Research 62
Countries citing papers authored by Li Xiao
This map shows the geographic impact of Li Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Xiao more than expected).
Fields of papers citing papers by Li Xiao
This network shows the impact of papers produced by Li Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Xiao. The network helps show where Li Xiao may publish in the future.
Co-authorship network of co-authors of Li Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Xiao. A scholar is included among the top collaborators of Li Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Xiao. Li Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 18 | |
| 4 | 26 | |
| 5 | 56 | |
| 6 | 18 | |
| 7 | 51 | |
| 8 | 32 | |
| 9 | 7 | |
| 10 | 15 | |
| 11 | MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis. | 19 |
| 12 | 20 | |
| 13 | 8 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 26 | |
| 17 | 32 | |
| 18 | [Immune tolerance induced by IL-10 and methylprednisolone modified dendritic cells in vitro]. | 6 |
| 19 | [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis]. | 4 |
About Li Xiao
Li Xiao is a scholar working on Hepatology, Reproductive Medicine and Periodontics, having authored 19 papers that have together received 351 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Hepatitis B Virus Studies (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Reproductive Medicine (77 citations), Hepatology (62 citations) and Periodontics (24 citations). Li Xiao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wei Huang, Hengxi Chen, Shuanghu Liu, Ling Cui, Curt H. Hagedorn, Jinke Li, Kefeng Dou, Xiaonan Zhang, Kaishan Tao and Zhuochao Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.